Biotechnology News FLOLAN Search

BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login

Search Results

Documents 1-8 out of 8 found

Current Search: flolan: 8

Gilead To Acquire Hypertension Drug Cicletanine From Navitas Assets, Terms Undisclosed
(FinancialWire) Gilead Sciences Inc.

(NASDAQ: GILD) has agreed to buy privately- held Navitas Assets' hypertension treatment Cicletanine for an undisclosed amount.

The drug is already approved in several European countries, though it has...

Calibre Macro World: May 30 2008 12:54PM
Matching: flolan

Find similar documents

Gilead buying hypertension drug from Navitas
NEW YORK Biotechnology company Gilead Sciences Inc.

said Thursday it will buy privately held Navitas Assets' hypertension treatment Cicletanine for an undisclosed amount, in a move to enhance its product pipeline.

The drug is already...

Business Week: May 30 2008 11:11AM
Matching: flolan

Find similar documents

Gilead buying hypertension drug from Navitas
NEW YORKBiotechnology company said Thursday it will buy privately held Navitas Assets' hypertension treatment Cicletanine for an undisclosed amount, in a move to enhance its product pipeline.The drug is already approved in several European...

Boston Globe: May 30 2008 12:16AM
Matching: flolan

Find similar documents

Gilead buying hypertension drug from Navitas
NEW YORK (AP) - Biotechnology company Gilead Sciences Inc.

said Thursday it will buy privately held Navitas Assets' hypertension treatment Cicletanine for an undisclosed amount, in a move to enhance its product pipeline.

The drug is...

AFX Press: May 29 2008 10:20PM
Matching: flolan

Find similar documents

Gilead buying hypertension drug from Navitas
NEW YORK (AP) - Biotechnology company Gilead Sciences Inc.

said Thursday it will buy privately held Navitas Assets' hypertension treatment Cicletanine for an undisclosed amount, in a move to enhance its product pipeline.

The drug is...

Sharewatch: May 29 2008 10:04PM
Matching: flolan

Find similar documents

Teva Introduces Epoprostenol Sodium for Injection
Teva Pharmaceutical Industries Ltd.

(Nasdaq: TEVA) announced today that the U.S.

Food and Drug Administration has granted approval for the Companys Abbreviated New Drug Application (ANDA) to market its epoprostenol, the first generic...

Pharma Live: Apr 30 2008 7:17PM
Matching: flolan

Find similar documents

Teva obtains approval for generic Flolan for injection
Teva's approval is for the 0.5mg base/vial and 1.5mg base/vial strengths as well as the sterile diluent.

This product is indicated for the long term intravenous treatment of primary pulmonary hypertension and pulmonary hypertension...

Pharmaceutical Business Review: Apr 29 2008 4:42PM
Matching: flolan

Find similar documents

Teva gets FDA approval of generic Flolan
SAN FRANCISCO (Thomson Financial) - Teva Pharmaceutical Industries Ltd.

said Monday the Food and Drug Administration has granted approval for the company's abbreviated new drug application to market its epoprostenol, a generic version of...

Sharewatch: Apr 28 2008 8:55PM
Matching: flolan

Find similar documents

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright � 1997-2008 - BioPortfolio Limited.